Application of romosozumab asa novel sclerostin inhibitor in the treatment of osteoporosis: from clinical trials to clinical applications

doi:10.13286/j.1001-5213.2021.01.22

CHEN Wen-wen, SUN Wen-wen, YIN Ling, GENG Tao, LIU Yan-lin, DANG He-qin

Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (1) : 115-118.

PDF(1416 KB)

Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (1) : 115-118. DOI: 10.13286/j.1001-5213.2021.01.22

CONTENTS IN BRIEF

Application of romosozumab asa novel sclerostin inhibitor in the treatment of osteoporosis: from clinical trials to clinical applications

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 41(1): 115-118 https://doi.org/10.13286/j.1001-5213.2021.01.22

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1416 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2020-08-01	2021-01-15
Issue Date
2021-02-06

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS

模态框（Modal）标题

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS